Avantor, Inc. (AVTR)
17.26
+0.64
(+3.85%)
USD |
NYSE |
Oct 21, 16:00
17.40
+0.14
(+0.81%)
Pre-Market: 20:00
Avantor Net Income (Annual) : -530.20M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -530.20M |
| December 31, 2024 | 711.50M |
| December 31, 2023 | 321.10M |
| December 31, 2022 | 686.50M |
| December 31, 2021 | 572.60M |
| December 31, 2020 | 116.60M |
| Date | Value |
|---|---|
| December 31, 2019 | 37.80M |
| December 31, 2018 | -86.90M |
| December 31, 2017 | -145.30M |
| December 31, 2016 | -80.70M |
| December 31, 2015 | 12.70M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Medpace Holdings, Inc. | 451.12M |
| Champions Oncology, Inc. | -1.175M |
| Personalis, Inc. | -81.27M |
| Adaptive Biotechnologies Corp. | -59.46M |
| 10X Genomics, Inc. | -43.54M |